<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page3_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page3_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>23</o:Revision>
  <o:TotalTime>231</o:TotalTime>
  <o:Created>2004-09-28T11:11:00Z</o:Created>
  <o:LastSaved>2004-10-05T13:21:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>401</o:Words>
  <o:Characters>2291</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>19</o:Lines>
  <o:Paragraphs>4</o:Paragraphs>
  <o:CharactersWithSpaces>2813</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
p
	{margin-right:0cm;
	mso-margin-top-alt:auto;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Unicode MS";}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
@list l0
	{mso-list-id:437718209;
	mso-list-type:hybrid;
	mso-list-template-ids:-173396714 -1932345934 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=blue style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page3_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page3_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>G Proteins<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>When G Protein Signalling is Disrupted <o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Mutations
in G proteins are involved in several diseases, ranging from Whooping Cough and
Cholera to several endocrine disorders.<span style="mso-spacerun: yes"> 
</span>G protein-related diseases are characterised by either deficient or
excessive G protein signal transmission, which arises through abnormal signal
initiation, defective termination, or reduced levels of G proteins.<span
style="mso-spacerun: yes">  </span>Perturbation of G-protein signalling is also
central to the actions of many drugs, including those used to treat asthma,
hypertension and depression.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Deficient
G protein signalling can arise through either reduced levels of G proteins, or
through decrease signal initiation.<span style="mso-spacerun: yes">  </span>Diseases
involving a decrease in the production of G proteins include Night Blindness,
where mutations in G(t) protein <span style='font-family:Symbol'>a</span>
subunits affect the response of rod cells to light; and Pseudohypoparathyroidism,
where the genetic loss of G(s) protein <span style='font-family:Symbol'>a</span>
subunits results in non-responsiveness to parathyroid hormone.<span
style="mso-spacerun: yes">  </span>Other abnormalities involve decreased signal
initiation through the inability of G proteins to switch to active states.<span
style="mso-spacerun: yes">  </span>For example, the symptoms of Whooping Cough
(Pertussis) result from the action of a bacterial toxin, which adds ADP-ribose
to the receptor-binding C-terminal tail of G(i) protein <span style='font-family:
Symbol'>a</span> subunits, causing a reduced responsiveness of G proteins to
receptor activation.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Excessive
G protein signalling can arise through either increased signal initiation, or defective
signal termination.<span style="mso-spacerun: yes">  </span>Increased signal
initiation occurs in Testotoxicosis, where a mutation in the receptor for luteinizing
hormone can over-stimulate G(s) proteins, resulting in the excessive production
of testosterone; in addition, several cases of Essential Hypertension arise
from mutations in G protein <span style='font-family:Symbol'>b</span> subunits.<span
style="mso-spacerun: yes">  </span>Diseases arising from defective signal
termination result from the persistent elevated activity of downstream
effectors, such as in Cholera, the symptoms of which results from the action of
a bacterial toxin that adds ADP-ribose to G(s) protein <span style='font-family:
Symbol'>a</span> subunits to prolong their activation, resulting in the
stimulation of adenylyl cyclase and the subsequent secretion of salt and water leading
to fatal diarrhoea.<span style="mso-spacerun: yes">  </span>Two other diseases
involve defective termination through mutations in G(s) protein <span
style='font-family:Symbol'>a</span> subunits, including Adenomas, in which G
proteins lose their ability to hydrolyse GTP through mutation, resulting in the
excessive secretion of growth hormone and the increased proliferation of somatotrophs;
and McCune-Albright Syndrome, where scattered regions of skin
hyper-pigmentation arise from the hyper-functioning of one or more endocrine
glands.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page4.htm" title="To next lage">What InterPro Tells Us</a></h1>

<h1 align=center style='text-align:center'>Previous:<span style="mso-spacerun:
yes">  </span><a href="Page2.htm" title="To previous page">How G Proteins Work</a></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p style='margin:0cm;margin-bottom:.0001pt'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

</div>

</body>

</html>
